Analyst Price Target is $1.29
▲ +143.42% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Charlotte's Web in the last 3 months. The average price target is $1.29, with a high forecast of $2.25 and a low forecast of $1.00. The average price target represents a 143.42% upside from the last price of $0.53.
Current Consensus is
The current consensus among 5 contributing investment analysts is to hold stock in Charlotte's Web. This rating has held steady since May 2021, when it changed from a Buy consensus rating.
Charlotte's Web Holdings, Inc. engages in farming, manufacturing, marketing, and selling hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies comprising sleep, stress, immunity, and exercise recovery products; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Denver, Colorado.